{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:02:29Z","timestamp":1762452149521,"version":"build-2065373602"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"crossref","award":["2020QNA060"],"award-info":[{"award-number":["2020QNA060"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Quanzhou High-level Talents Innovation and Entrepreneurship Project","award":["2024QZC005YR"],"award-info":[{"award-number":["2024QZC005YR"]}]},{"name":"Fujian Provincial Key Laboratory of Innovative Drug Target Research","award":["FJ-YW-2024KF06"],"award-info":[{"award-number":["FJ-YW-2024KF06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10822-025-00635-y","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T14:14:37Z","timestamp":1752848077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design, synthesis, evaluation and molecular modeling of quinazoline derivatives bearing amino acids as small-molecule PD-L1 inhibitors"],"prefix":"10.1007","volume":"39","author":[{"given":"Han","family":"Liu","sequence":"first","affiliation":[]},{"given":"Roufen","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Dandan","family":"Yuan","sequence":"additional","affiliation":[]},{"given":"Yidan","family":"Xing","sequence":"additional","affiliation":[]},{"given":"Xueyan","family":"Ding","sequence":"additional","affiliation":[]},{"given":"Xingye","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Yali","family":"Gao","sequence":"additional","affiliation":[]},{"given":"Junjie","family":"Ma","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"3","key":"635_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwidee for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"635_CR2","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1080\/17425247.2021.1882992","volume":"18","author":"Y Fang","year":"2021","unstructured":"Fang Y, Yu A, Ye L, Zhai G (2021) Research progress in tumor targeted immunotherapy. Expert Opin Drug Deliv 18(8):1067\u20131090. https:\/\/doi.org\/10.1080\/17425247.2021.1882992","journal-title":"Expert Opin Drug Deliv"},{"key":"635_CR3","doi-asserted-by":"publisher","first-page":"1212476","DOI":"10.3389\/fimmu.2023.1212476","volume":"14","author":"R Rui","year":"2023","unstructured":"Rui R, Zhou L, He S (2023) Cancer immunotherapies: advances and bottlenecks. Front Immunol 14:1212476. https:\/\/doi.org\/10.3389\/fimmu.2023.1212476","journal-title":"Front Immunol"},{"issue":"7637","key":"635_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I (2017) Elements of cancer immunity and the cancer-immune set point. Nature 541(7637):321\u2013330. https:\/\/doi.org\/10.1038\/nature21349","journal-title":"Nature"},{"issue":"9","key":"635_CR5","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.7150\/jca.57334","volume":"12","author":"C Ghosh","year":"2021","unstructured":"Ghosh C, Luong G, Sun Y (2021) A snapshot of the PD-1\/PD-L1 pathway. J Cancer 12(9):2735\u20132746. https:\/\/doi.org\/10.7150\/jca.57334","journal-title":"J Cancer"},{"issue":"4","key":"635_CR6","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s11030-022-10509-2","volume":"27","author":"X Li","year":"2023","unstructured":"Li X, Zeng Q, Xu F, Jiang Y, Jiang Z (2023) Progress in programmed cell death-1\/programmed cell death-ligand 1 pathway inhibitors and binding mode analysis. Mol Divers 27(4):1935\u20131955. https:\/\/doi.org\/10.1007\/s11030-022-10509-2","journal-title":"Mol Divers"},{"issue":"4","key":"635_CR7","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1021\/acs.jmedchem.8b00990","volume":"62","author":"T Wang","year":"2019","unstructured":"Wang T, Wu X, Guo C, Zhang K, Xu J, Li Z, Jiang S (2019) Development of inhibitors of the programmed cell Death-1\/Programmed cell Death-Ligand 1 signaling pathway. J Med Chem 62(4):1715\u20131730. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00990","journal-title":"J Med Chem"},{"issue":"3","key":"635_CR8","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.apsb.2023.12.010","volume":"14","author":"F Wang","year":"2024","unstructured":"Wang F, Fu K, Wang Y, Pan C, Wang X, Liu Z, Yang C, Zheng Y, Li X, Lu Y, To KKW, Xia C, Zhang J, Shi Z, Hu Z, Huang M, Fu L (2024) Small-molecule agents for cancer immunotherapy. Acta Pharm Sinica B 14(3):905\u2013952. https:\/\/doi.org\/10.1016\/j.apsb.2023.12.010","journal-title":"Acta Pharm Sinica B"},{"issue":"1","key":"635_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41401-020-0366-x","volume":"42","author":"Q Wu","year":"2021","unstructured":"Wu Q, Jiang L, Li SC, He QJ, Yang B, Cao J (2021) Small molecule inhibitors targeting the PD-1\/PD-L1 signaling pathway. Acta Pharmacol Sin 42(1):1\u20139. https:\/\/doi.org\/10.1038\/s41401-020-0366-x","journal-title":"Acta Pharmacol Sin"},{"key":"635_CR10","doi-asserted-by":"publisher","first-page":"115465","DOI":"10.1016\/j.ejmech.2023.115465","volume":"256","author":"N Boisgerault","year":"2023","unstructured":"Boisgerault N, Bertrand P (2023) Inside PD-1\/PD-L1,2 with their inhibitors. Eur J Med Chem 256:115465. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115465","journal-title":"Eur J Med Chem"},{"issue":"2","key":"635_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4155\/fmc-2021-0256","volume":"14","author":"R Chen","year":"2022","unstructured":"Chen R, Yuan D, Ma J (2022) Advances of biphenyl small-molecule inhibitors targeting PD-1\/PD-L1 interaction in cancer immunotherapy. Future Med Chem 14(2):97\u2013113. https:\/\/doi.org\/10.4155\/fmc-2021-0256","journal-title":"Future Med Chem"},{"key":"635_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s40242-019-8310-7","volume":"35","author":"J Ma","year":"2019","unstructured":"Ma J, Huang K, Ni X, Chen R, Xu B, Wang C (2019) Design, synthesis, biological activity and molecular Docking study of coumarin derivatives bearing 2-Methylbiphenyl moiety. Chem Res Chin Univ 35:410\u2013417. https:\/\/doi.org\/10.1007\/s40242-019-8310-7","journal-title":"Chem Res Chin Univ"},{"key":"635_CR13","doi-asserted-by":"publisher","first-page":"113998","DOI":"10.1016\/j.ejmech.2021.113998","volume":"229","author":"Y Wang","year":"2022","unstructured":"Wang Y, Kun Huang, Gao Y, Yuan D, Ling L, Liu J, Wu S, Chen R, Li H, Xiong Y, Liu H, Ma J (2022) Discovery of Quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1\/programmed cell death-ligand 1 (PD-1\/PD-L1) interaction. Eur J Med Chem 229:113998. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113998","journal-title":"Eur J Med Chem"},{"issue":"4","key":"635_CR14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1021\/acsmedchemlett.4c00014","volume":"15","author":"X Wu","year":"2024","unstructured":"Wu X, Li H, Liu H, Ding X, Chen X, Yin C, Gao Y, Ma J (2024) Design, synthesis, and evaluation of 8-(o-Tolyl)quinazoline derivatives as Small-Molecule PD-1\/PD-L1 antagonists. ACS Med Chem Lett 15(4):518\u2013523. https:\/\/doi.org\/10.1021\/acsmedchemlett.4c00014","journal-title":"ACS Med Chem Lett"},{"issue":"9","key":"635_CR15","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1021\/acs.jmedchem.9b00312","volume":"62","author":"M Qin","year":"2019","unstructured":"Qin M, Cao Q, Zheng S, Tian Y, Zhang H, Xie J, Xie H, Liu Y, Zhao Y, Gong P (2019) Discovery of [1,2,4]Triazolo[4,3- a]pyridines as potent inhibitors targeting the programmed cell Death-1\/Programmed cell Death-Ligand 1 interaction. J Med Chem 62(9):4703\u20134715. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00312","journal-title":"J Med Chem"},{"issue":"11","key":"635_CR16","doi-asserted-by":"publisher","first-page":"7390","DOI":"10.1021\/acs.jmedchem.1c00010","volume":"64","author":"T Wang","year":"2021","unstructured":"Wang T, Cai S, Wang M, Zhang W, Zhang K, Chen D, Li Z, Jiang S (2021) Novel biphenyl pyridines as potent Small-Molecule inhibitors targeting the programmed cell Death-1\/Programmed cell Death-Ligand 1 interaction. J Med Chem 64(11):7390\u20137403. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00010","journal-title":"J Med Chem"},{"issue":"4","key":"635_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.19728\/j.issn1672-6634.2023020013","volume":"36","author":"K Huang","year":"2023","unstructured":"Huang K, Ma J (2023) Design, synthesis, PD-1\/PD-L1 inhibitory activity screening and molecular Docking study of biphenyl compounds bearing triazine structure. J Liaocheng Univ (Natural Sci Edition) 36(4):82\u201392. https:\/\/link.cnki.net\/doi\/https:\/\/doi.org\/10.19728\/j.issn1672-6634.2023020013","journal-title":"J Liaocheng Univ (Natural Sci Edition)"},{"issue":"15","key":"635_CR18","doi-asserted-by":"publisher","first-page":"11614","DOI":"10.1021\/acs.jmedchem.1c00957","volume":"64","author":"D Muszak","year":"2021","unstructured":"Muszak D, Surmiak E, Plewka J, Magiera-Mularz K, Kocik-Krol J, Musielak B, Sala D, Kitel R, Stec M, Weglarczyk K, Siedlar M, D\u00f6mling A, Skalniak L, Holak TA (2021) Terphenyl-Based Small-Molecule inhibitors of programmed cell Death-1\/Programmed Death-Ligand 1 Protein-Protein interaction. J Med Chem 64(15):11614\u201311636. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00957","journal-title":"J Med Chem"},{"issue":"5","key":"635_CR19","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1021\/acs.jmedchem.3c02362","volume":"67","author":"Y Xu","year":"2024","unstructured":"Xu Y, Du H, Guo W, Liu B, Yan W, Zhang C, Qin L, Huang J, Wang H, Wu S, Ren W, Zou Y, Wang J, Zhu Q, Xu Y, Gu H (2024) Discovery of highly potent Small-Molecule PD-1\/PD-L1 inhibitors with a novel scaffold for Cancer immunotherapy. J Med Chem 67(5):4083\u20134099. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c02362","journal-title":"J Med Chem"},{"issue":"24","key":"635_CR20","doi-asserted-by":"publisher","first-page":"16807","DOI":"10.1021\/acs.jmedchem.3c01534","volume":"66","author":"K Wang","year":"2023","unstructured":"Wang K, Zhang X, Cheng Y, Qi Z, Ye K, Zhang K, Jiang S, Liu Y, Xiao Y, Wang T (2023) Discovery of novel PD-L1 inhibitors that induce the dimerization, internalization, and degradation of PD-L1 based on the fragment coupling strategy. J Med Chem 66(24):16807\u201316827. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c01534","journal-title":"J Med Chem"},{"issue":"12","key":"635_CR21","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1016\/j.apsb.2022.09.022","volume":"12","author":"K Tang","year":"2022","unstructured":"Tang K, Wang S, Gao W, Song Y, Yu B (2022) Harnessing the cyclization strategy for new drug discovery. Acta Pharm Sin B 12(12):4309\u20134326. https:\/\/doi.org\/10.1016\/j.apsb.2022.09.022","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"635_CR22","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1021\/acs.jmedchem.1c02156","volume":"65","author":"C Li","year":"2022","unstructured":"Li C, Su M, Zhu W, Kan W, Ge T, Xu G, Wang S, Sheng L, Gao F, Ye Y, Wang J, Zhou Y, Li J, Liu H (2022) Structure-Activity relationship study of Indolin-5-yl-cyclopropanamine derivatives as selective lysine specific demethylase 1 (LSD1) inhibitors. J Med Chem 65(5):4335\u20134349. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c02156","journal-title":"J Med Chem"},{"issue":"16","key":"635_CR23","doi-asserted-by":"publisher","first-page":"11934","DOI":"10.1021\/acs.jmedchem.1c00459","volume":"64","author":"H Cho","year":"2021","unstructured":"Cho H, Shin I, Yoon H, Jeon E, Lee J, Kim Y, Ryu S, Song C, Kwon NH, Moon Y, Kim S, Kim ND, Choi HG, Sim T (2021) Identification of Thieno[3,2-d]pyrimidine derivatives as dual inhibitors of focal adhesion kinase and FMS-like tyrosine kinase 3. J Med Chem 64(16):11934\u201311957. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00459","journal-title":"J Med Chem"},{"issue":"16","key":"635_CR24","doi-asserted-by":"publisher","first-page":"10992","DOI":"10.1021\/acs.jmedchem.2c00081","volume":"65","author":"K Yang","year":"2022","unstructured":"Yang K, Li S, Wang T, Yan X, He Q, Ning R, Xu X, Yao W, Zhang X, Yang C, Jiang M, Deng L (2022) Development of an orally active Small-Molecule inhibitor of receptor activator of nuclear Factor-\u03baB ligand. J Med Chem 65(16):10992\u201311009. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00081","journal-title":"J Med Chem"},{"issue":"22","key":"635_CR25","doi-asserted-by":"publisher","first-page":"13825","DOI":"10.1021\/acs.jmedchem.0c01329","volume":"63","author":"J Guo","year":"2022","unstructured":"Guo J, Luo L, Wang Z, Hu N, Wang W, Xie F, Liang E, Yan X, Xiao J, Li S (2022) Design, synthesis, and biological evaluation of linear aliphatic Amine-Linked triaryl derivatives as potent Small-Molecule inhibitors of the programmed cell Death-1\/Programmed cell Death-Ligand 1 interaction with promising antitumor effects in vivo. J Med Chem 63(22):13825\u201313850. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01329","journal-title":"J Med Chem"},{"issue":"15","key":"635_CR26","doi-asserted-by":"publisher","first-page":"10579","DOI":"10.1021\/acs.jmedchem.3c00731","volume":"66","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhou S, Plewka J, Wu C, Zhu M, Yu Q, Musielak B, Wang X, Awadasseid A, Magiera-Mularz K et al (2023) Design, synthesis, and antitumor activity evaluation of 2-Arylmethoxy-4-(2,2\u2032-dihalogen-substituted biphenyl-3-ylmethoxy) benzylamine derivatives as potent PD-1\/PD-L1 inhibitors. J Med Chem 66(15):10579\u201310603. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c00731","journal-title":"J Med Chem"},{"issue":"14","key":"635_CR27","doi-asserted-by":"publisher","first-page":"167994","DOI":"10.1016\/j.jmb.2023.167994","volume":"435","author":"S Bittrich","year":"2023","unstructured":"Bittrich S, Bhikadiya C, Bi C, Chao H, Duarte JM, Dutta S, Fayazi M, Henry J, Khokhriakov I, Lowe R, Piehl DW, Segura J, Vallat B, Voigt M, Westbrook JD, Burley SK, Rose Y (2023) RCSB protein data bank: efficient searching and simultaneous access to one million computed structure models alongside the PDB structures enabled by architectural advances. J Mol Biol 435(14):167994. https:\/\/doi.org\/10.1016\/j.jmb.2023.167994","journal-title":"J Mol Biol"},{"issue":"16","key":"635_CR28","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated Docking with selective receptor flexibility. J Comput Chem 30(16):2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"issue":"2","key":"635_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock vina: improving the speed and accuracy of Docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"635_CR30","unstructured":"Schr\u00f6dinger LLC (2024) The PyMOL Molecular Graphics System, Version 3. https:\/\/www.pymol.org\/"},{"key":"635_CR31","doi-asserted-by":"publisher","unstructured":"Tubiana T (2024) tubiana\/protocolGromacs: Gromacs protocol 06-07-2024. https:\/\/doi.org\/10.5281\/zenodo.11517765","DOI":"10.5281\/zenodo.11517765"},{"key":"635_CR32","doi-asserted-by":"publisher","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, Lindahl E (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, pp 19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","DOI":"10.1016\/j.softx.2015.06.001"},{"key":"635_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1756-0500-5-367","volume":"5","author":"AW Sousa da Silva","year":"2012","unstructured":"Sousa da Silva AW, Vranken WF (2012) ACPYPE-AnteChamber Python parser interface. BMC Res Notes 5:367. https:\/\/doi.org\/10.1186\/1756-0500-5-367","journal-title":"BMC Res Notes"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00635-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00635-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00635-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:56:22Z","timestamp":1762451782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00635-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["635"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00635-y","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}